NASDAQ: EXAI - Exscientia Holdings Limited

Yield per half year: -7.85%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Exscientia Holdings Limited

Extended chart Simple chart
Financial Markets by TradingView

About Exscientia Holdings Limited

Exscientia plc, фармацевтическая компания, основанная на искусственном интеллекте, занимается открытием, проектированием и разработкой лекарств. Он предлагает комплексное решение с использованием искусственного интеллекта и технологий для идентификации целей, разработки кандидатов на лекарства, трансляционных моделей и отбора пациентов. Его платформа позволяет разрабатывать молекулы-кандидаты в лекарственные препараты, а также предоставлять пациентам лекарственную терапию с помощью оценки под руководством ИИ.

more details
Компания была основана в 2012 году, ее штаб-квартира находится в Оксфорде, Великобритания.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-10-01
ISIN US30223G1022
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://www.exscientia.ai
Цена ао 4.58
Change price per day: -0.4348% (4.6)
Change price per week: -13.58% (5.3)
Change price per month: -6.15% (4.88)
Change price per 3 month: -14.71% (5.37)
Change price per half year: -7.85% (4.97)
Change price per year: -2.14% (4.68)
Change price per year to date: -15.03% (5.39)
All parameters

Underestimation

Title Value Grade
P/S 28.18 1
P/BV 1.49 9
P/E 0 0
EV/EBITDA -1.9 0
Total: 3.38

Efficiency

Title Value Grade
ROA, % -20.33 0
ROE, % -33.79 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0861 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 65.41 8
Yield Ebitda, % 1753.87 10
Yield EPS, % 3263.43 10
Total: 7.6
More

Institutions Volume Share, %
Marshall Wace LLP 995 0.82
Nan Fung Group Holdings Limited 860 0.71
Softbank Group Corporation 6 4.7
Laurion Capital Management, LP 5 4.47
Baillie Gifford and Company 5 3.78
Platinum Investment Management Ltd 4 3.26
Woodline Partners LP 2 1.37
Bill & Melinda Gates Foundation 2 1.32
MIC Capital Management UK LLP 2 1.28
First Trust Advisors LP 1 1.18

ETFShare, %Profitability for 1 year, %Dividends, %
Principal Healthcare Innovators ETF 0.0252 618.5 0.8416
Future Tech ETF 0.0252 426.34 0.8416
0.03522.420.84



Head Job title Payment Year of birth
Mr. Ben R. Taylor CFO, Chief Strategy Officer & Executive Director 531.62k 1977 (48 years)
Ms. Sara Sherman Vice President of Investor Relations N/A
Mr. Dan Ireland Executive VP of Legal & Company Secretary N/A
Dr. David Hallett Ph.D. Chief Scientific Officer, Interim CEO, Principal Executive Officer & Executive Director N/A 1969 (56 years)
Ms. Caroline Rowland Chief People Officer N/A
Mr. Richard Law Chief Business Officer N/A
Mr. Parker Moss Executive Vice President of Corporate Development N/A
Dr. John P. Overington Ph.D. Chief Technology Officer N/A
Mr. Nikolaus Krall Executive Vice President of Precision Medicine
Dr. Marie-Louise Helena Fjallskog M.D., Ph.D. Interim Chief Medical Officer & Clinical Development Lead 1964 (61 year)

Address: United Kingdom, Oxford, The SchrOedinger Building - open in Google maps, open in Yandex maps
Website: https://www.exscientia.ai